← back to search

Christine Pirker

Center for Cancer Research · US
Area of research
Pulmonary and Respiratory Medicine · Biotechnology
Research interest
Research interests include Biology, Cancer research, Telomerase, Telomerase reverse transcriptase, Telomere, and Molecular biology.
h-index
citations
341
works
10
NIH funding
primary concept
email

Recent publications

Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens
Neuro-Oncology 2024cited by 11position: middledoi
Influence of the Fatty Acid Metabolism on the Mode of Action of a Cisplatin(IV) Complex with Phenylbutyrate as Axial Ligands
Pharmaceutics 2023cited by 7position: middledoi
Targeting fibroblast growth factor receptors to combat aggressive ependymoma
Acta Neuropathologica 2021cited by 33position: middledoi
Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup
Clinical Cancer Research 2020cited by 45position: firstdoi
TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAFV600E/TERT promoter double-mutated glioma
Acta Neuropathologica Communications 2019cited by 43position: middledoi
<i>TERT</i>promoter mutations are associated with poor prognosis and cell immortalization in meningioma
Neuro-Oncology 2018cited by 137position: middledoi
P02.10 Aggressiveness of meningiomas is predicted by cell immortalization in vitro and dependent on TERT promoter mutations
Neuro-Oncology 2018cited by 1position: middledoi
PCLN-06. NOVEL TUMOR-DERIVED MODELS OF CNS HGNET-BCOR PROVIDE INSIGHTS INTO UNDERLYING MOLECULAR MECHANISMS AND INNOVATIVE THERAPEUTIC OPTIONS
Neuro-Oncology 2018cited by 0position: middledoi
Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma
Journal of Thoracic Oncology 2017cited by 53position: middledoi
MAP kinase activity supported by BRAF V600E mutation rather than gene amplification is associated with ETV1 expression in melanoma brain metastases
Archives of Dermatological Research 2014cited by 11position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Walter Berger · Comprehensive Cancer Center Vienna7 papers (2014–2023)Johannes Gojo · University of Hong Kong4 papers (2018–2019)Daniela Lötsch · University Hospital Heidelberg4 papers (2018–2019)Katharina Neumayer · University Hospital Heidelberg3 papers (2018–2019) · 3 papers (2018–2019)Sabine Spiegl‐Kreinecker · University Hospital Heidelberg3 papers (2018–2019)Rajiv Kumar · National Remote Sensing Centre3 papers (2018–2019)Irene Slavc · Universitätsklinik für Kinder und Jugendpsychiatrie2 papers (2018–2019) · 2 papers (2018–2018)Thomas Czech · Vienna General Hospital2 papers (2018–2019) · 2 papers (2018–2018) · 2 papers (2018–2018)Christine Haberler · Sapienza University of Rome2 papers (2018–2019)Dominik Kirchhofer · Center for Cancer Research2 papers (2018–2019)Andreas Peyrl · University of Hong Kong2 papers (2018–2019) · 2 papers (2014–2019)Dominik Sturm · German Cancer Research Center1 papers (2018–2018) · 1 papers (2018–2018) · 1 papers (2023–2023)Marissa Williams · The University of Sydney1 papers (2017–2017)